Spago Nanomedical Publishes the Annual Report for 2025
LUND, SE / ACCESS Newswire / May 19, 2026 /Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)
Spago Nanomedical 's annual report for 2025 is from today available at the company 's website, https://spagonanomedical.se/investor-relations/#financial-reports
For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, mats.hansen@spagonanomedical.se
Spago Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise treatment and diagnosis of cancer and other debilitating diseases. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, seewww.spagonanomedical.se.
FNCA Sweden AB is the Certified Adviser of the company.
Attachments
Spago Nanomedical AB Annual Report 2025
SOURCE: Spago Nanomedical
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
